Key Highlights

  • Actinogen Medical Ltd (ASX: ACW) shares closed unchanged during the 13 August 2026 session.
  • The stock traded within a narrow intraday range on notable volume.
  • Market capitalisation remained above the $170 million mark at close.
  • The one-year performance figure showed an increase compared to twelve months earlier.
  • The Health Care sector index recorded a modest gain for the session.

Overview

Actinogen Medical Ltd, trading under the ticker code ACW on the Australian Securities Exchange (ASX), is part of the S&P/ASX 200 Health Care sector. This article presents a factual, educational summary of the company's share price activity for the session ending 13 August 2026, based only on figures recorded at market close on that date, and should not be read as a recommendation regarding the stock.

Share Price Movement

Actinogen Medical Ltd shares closed the session at $0.046, unchanged from the previous close, recording a percentage change of 0%. This means the stock's price neither rose nor fell over the course of the day, closing at the same level it opened the session against. During the session, the share price moved between an intraday high of $0.047 and an intraday low of $0.046, a narrow range consistent with a session that finished flat.

A flat close does not necessarily mean an absence of trading activity, as the figures below show, but rather that buying and selling pressure balanced out by the end of the session.

Trading Volume and Market Capitalisation

A total of 5,130,328 shares were traded during the 13 August 2026 session, representing meaningful trading volume despite the price finishing unchanged. This figure indicates that a notable number of shares changed hands even though the closing price matched the previous session's close.

At the closing price, Actinogen Medical Ltd's Market Capitalisation stood at approximately $171.09 million, placing it among the mid-to-smaller sized companies within the listed Health Care sector.

One-Year Performance

Over the twelve months to 13 August 2026, Actinogen Medical Ltd shares recorded a change of approximately 84%, indicating that the share price was higher than it stood a year earlier. This annual figure reflects the net outcome of movements across the full period rather than a description of a steady trend.

Health Care Sector Snapshot

The stock is part of the S&P/ASX 200 Health Care Index (ASX: XHJ), which closed the 13 August 2026 session at 29,014.4 points, up 50.0 points, or 0.17%, from the previous close of 28,964.4 points. During the session, the index moved between a day high of 29,130.7 points and a day low of 28,777.6 points. Over the past 52 weeks, the index has ranged between 21,947.2 points and 45,579.6 points, and it has recorded a decline of 35.29% on a one-year basis. This sector-level movement provides context for the individual performance of health care stocks listed on the exchange, though each company's price behaviour is also shaped by its own trading activity.

Conclusion

In summary, Actinogen Medical Ltd (ASX: ACW) shares closed the 13 August 2026 session unchanged, having traded within a narrow range on notable volume. The company's market capitalisation and its one-year performance figure, considered alongside the movement of the S&P/ASX 200 Health Care Index, provide a factual, point-in-time snapshot for readers. This article is intended for general educational purposes only and does not constitute financial advice.

Frequently Asked Questions (FAQs)